Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J SMALL

Showing results (1011-1020 of 1,203) with videos related to

Pageof 121
Sort By:
Prostate Cancer and Prostatic Diseases|October 8, 2022
Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamideYaoYao Pollock, Matthew R Smith, Fred Saad, et al.
Head & Neck|May 4, 2023
Patient-reported outcomes in immunotherapy for head and neck cancerKedar Kirtane, Aasha I Hoogland, Xiaoyin Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancerE J Small, F Saad, S Chowdhury, et al.
Journal of Invertebrate Pathology|March 22, 2012
Disease will limit future food supply from the global crustacean fishery and aquaculture sectorsG D Stentiford, D M Neil, E J Peeler, et al.
The New England Journal of Medicine|October 8, 2004
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancerDaniel P Petrylak, Catherine M Tangen, Maha H A Hussain, et al.
Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.
Diabetes|June 27, 2000
Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormoneM S Kim, M Rossi, S Abusnana, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 28, 2024
Feasibility and acceptability of C-PRIME: A health promotion intervention for family caregivers of patients with colorectal cancerLisa M Gudenkauf, Xiaoyin Li, Aasha I Hoogland, et al.
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
Pageof 121

Showing results (1011-1020 of 1,203) with videos related to

Sort By:
Pageof 121
Prostate Cancer and Prostatic Diseases|October 8, 2022
Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamideYaoYao Pollock, Matthew R Smith, Fred Saad, et al.
Head & Neck|May 4, 2023
Patient-reported outcomes in immunotherapy for head and neck cancerKedar Kirtane, Aasha I Hoogland, Xiaoyin Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancerE J Small, F Saad, S Chowdhury, et al.
Journal of Invertebrate Pathology|March 22, 2012
Disease will limit future food supply from the global crustacean fishery and aquaculture sectorsG D Stentiford, D M Neil, E J Peeler, et al.
The New England Journal of Medicine|October 8, 2004
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancerDaniel P Petrylak, Catherine M Tangen, Maha H A Hussain, et al.
Nature Cell Biology|June 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progressionMeng Zhang, Martin Sjöström, Xiekui Cui, et al.
Diabetes|June 27, 2000
Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormoneM S Kim, M Rossi, S Abusnana, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 28, 2024
Feasibility and acceptability of C-PRIME: A health promotion intervention for family caregivers of patients with colorectal cancerLisa M Gudenkauf, Xiaoyin Li, Aasha I Hoogland, et al.
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
Pageof 121